166 related articles for article (PubMed ID: 9531598)
21. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.
Kater AP; Dicker F; Mangiola M; Welsh K; Houghten R; Ostresh J; Nefzi A; Reed JC; Pinilla C; Kipps TJ
Blood; 2005 Sep; 106(5):1742-8. PubMed ID: 15914559
[TBL] [Abstract][Full Text] [Related]
23. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
Chu P; Wierda WG; Kipps TJ
Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920
[TBL] [Abstract][Full Text] [Related]
24. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
[TBL] [Abstract][Full Text] [Related]
25. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
Buske C; Twiling A; Gogowski G; Schreiber K; Feuring-Buske M; Wulf GG; Hiddemann W; Wörmann B
Leukemia; 1997 Nov; 11(11):1862-7. PubMed ID: 9369419
[TBL] [Abstract][Full Text] [Related]
26. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma.
Kim LH; Eow GI; Peh SC; Poppema S
Pathology; 2003 Oct; 35(5):428-35. PubMed ID: 14555388
[TBL] [Abstract][Full Text] [Related]
27. Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands.
Laytragoon-Lewin N
Med Oncol; 1998 Apr; 15(1):15-9. PubMed ID: 9643525
[TBL] [Abstract][Full Text] [Related]
28. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.
Cleary AM; Fortune SM; Yellin MJ; Chess L; Lederman S
J Immunol; 1995 Oct; 155(7):3329-37. PubMed ID: 7561026
[TBL] [Abstract][Full Text] [Related]
29. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
30. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
31. CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells.
Kim D; Hur DY; Kim YS; Lee K; Lee Y; Cho D; Kang JS; Kim YI; Hahm E; Yang Y; Yoon S; Kim S; Lee WB; Park HY; Kim YB; Hwang YI; Chang KY; Lee WJ
Hum Immunol; 2002 Jul; 63(7):576-87. PubMed ID: 12072193
[TBL] [Abstract][Full Text] [Related]
32. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis.
Jakobson E; Jönsson G; Björck P; Paulie S
Int J Cancer; 1998 Sep; 77(6):849-53. PubMed ID: 9714053
[TBL] [Abstract][Full Text] [Related]
34. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.
Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A
Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019
[TBL] [Abstract][Full Text] [Related]
35. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.
Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A
Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508
[TBL] [Abstract][Full Text] [Related]
36. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
Dicker F; Kater AP; Fukuda T; Kipps TJ
Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
[TBL] [Abstract][Full Text] [Related]
37. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
Lee JR; Koretzky GA
J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
[TBL] [Abstract][Full Text] [Related]
38. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
[TBL] [Abstract][Full Text] [Related]
39. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation.
Nakanishi K; Matsui K; Kashiwamura S; Nishioka Y; Nomura J; Nishimura Y; Sakaguchi N; Yonehara S; Higashino K; Shinka S
Int Immunol; 1996 May; 8(5):791-8. PubMed ID: 8671668
[TBL] [Abstract][Full Text] [Related]
40. Unbalanced expression of Fas and CD40 in mantle cell lymphoma.
Clodi K; Snell V; Zhao S; Cabanillas F; Andreeff M; Younes A
Br J Haematol; 1998 Oct; 103(1):217-9. PubMed ID: 9792311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
